Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

Myriad Genetics and CancerCARE for Life announced an agreement designed to enhance education and access to hereditary cancer testing.